Global RSV Diagnostics Market Report and Forecast 2024-2032

Global RSV Diagnostics Market Outlook

The global RSV diagnostics market attained a value of about USD 1028.55 million in 2023. The market is further expected to grow at a CAGR of 10.2% during the forecast period of 2024-2032 to reach nearly USD 2465.26 million by 2032.

The Increasing Prevalence of RSV Disease Invigorating the Market Growth of RSV Diagnostics

The global market for RSV diagnostics is being driven by the increasing prevalence of RSV disorder, especially among children below the age of two years. The respiratory syncytial virus is a common and contagious virus that infects the respiratory tract causing breathing problems. Factors such as increasing investments into healthcare infrastructure in conjunction with the rising focus of parents on child medical care are positively impacting the growth of the market.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

As the symptoms of RSV are similar to other respiratory disorders, the need for rapid, specific, and effective diagnostics is invigorating the growth of the market. Furthermore, the increasing awareness regarding the high survival rates after early diagnosis and the easy availability of diagnostics modalities are further positively influencing the overall market growth of RSV diagnostics. The market is further augmented by favourable government measures, such as reimbursement policies, awareness camps, and free diagnostics, among others.

RSV Diagnostics Market Segmentation

Respiratory syncytial virus (RSV) is a viral infection of the lungs and respiratory tract, which causes asthma, pneumonia, middle ear infections, and sometimes death if left untreated. The diagnostics methods for RSV include blood tests, chest x-rays, checking for white blood cell (WBC) and oxygen levels in the blood, and swab secretions.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

On the basis of product, the market can be divided into:

• Direct Fluorescent Antibody (DFA) Method
• Rapid Antigen Diagnostic Test (RADT) 
• Molecular Diagnostics
• Chromatographic Immunoassay
• Diagnostic Imaging 
• Gel Microdroplets
• Flow Cytometry
• Others

Chromatographic immunoassay can be further divided into gravity driven test and oligochromatography.

Based on end-use, the market can be segmented into:

• Hospitals
• Laboratory
• Clinics 
• Homecare

The EMR report looks into the regional markets of RSV diagnostics like North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.

Improved Healthcare Technologies to Propel the Market Growth of RSV Diagnostics

The growth in the global market of RSV diagnostics is expected to be driven by the advent of advanced techniques, including bio-and nanotechnology facilitating the development of modern detection systems for RSV, such as western bolt, enzyme linked immunosorbent assay (ELISA), direct immunofluorescence, and real-time polymerase chain reaction (PCR). In addition, the nucleic acid amplification techniques and loop-mediated isothermal amplification aligned with point of care (POC) devices are expected to augment the growth of the market in the coming years by allowing testing to be performed using a one-step kit requiring only the addition of a patient sample. In addition to this, fast approvals by the FDA, government and private funding into the healthcare structure, and robust investments into the research and development (R&D) programmes are further expected to drive the market growth of RSV diagnostics over the forecast period.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Key Industry Players in the Global RSV Diagnostics Market

The report presents a detailed analysis of the following key players in the global RSV diagnostics market, looking into their capacity, market share, and latest developments like capacity expansions, plant turnabouts and mergers and acquisitions:

• Abbott Laboratories
• Thermo Fisher Scientific Inc.
• F. Hoffmann-La Roche Ltd
• Becton, Dickinson and Company
• bioMérieux SA
• DiaSorin Molecular LLC
• Others

The comprehensive report looks at the micro and macro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of the Porter’s Five Forces Model.

Key Highlights of the Report